Ledger.Open graph →
SEC Form D · filed October 4, 2022

Vaxess Technologies, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Fenel M. Eloi · Cambridge, MADirectorLivio M. Valenti · Cambridge, MAExecJonathan M. Kluge · Cambridge, MAExecMichael Schrader · Cambridge, MAExec · DirectorLynda M. Tussey · Cambridge, MAExecKathryn Kosuda · Cambridge, MAExec · DirectorMario Barro · Cambridge, MADirectorAnn Dewitt · Cambridge, MADirectorRobert Burkley · New York, NYExecSean Slovenski · Bedford, MAExec · DirectorTim O'Toole · Bedford, MAExec · DirectorByron Boots · Seattle, WAExecSteve Pattyn · New York, NYExecPaula Schneider · Bedford, MADirectorJonathan Fink · Seattle, WADirectorLisa Flaherty · New York, NYDirectorMikel Durham · Biddeford, MEExec · DirectorJames Lindsay · Biddeford, MEDirectorCharles A. Henry · Mishawaka, INDirectorJohn W. Rosenthal · Mishawaka, INExecAntonio Secondo C. Mazzola Renato · New York, NYExecTodd Pence · Pepper Pike, OHExec · DirectorHamilton Dr. Helmer · Los Altos, CAExecJohn Rutherford · Miami Beach, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗